Quantum Biopharma Ltd (QNTM) Stock Price, Quote & News

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is...

Industry: Biotechnology

Sector: Healthcare

Phone: 833 571 1811

Website: www.quantumbiopharma.com

Address:

55 University Avenue, Suite 1003, Toronto, Canada

HeyHoser Oct. 7 at 1:55 PM

$QNTM no biggie.

0 · Reply

NeckDart Oct. 6 at 10:54 PM

$CCCX $QBTS $RGTI $QNTM 🤟

0 · Reply

gloryb Oct. 6 at 9:19 PM

$QNTM fkn joke

0 · Reply

NoFearHere Oct. 6 at 7:57 PM

$QNTM the dividend is only based upon receiving the money from the lawsuit any appeal process and etc etc will eliminate the date of the Divi and the Divi itself if they lose

0 · Reply

NoFearHere Oct. 6 at 3:11 PM

$QNTM well a DIVY is expected once court decisions reached...anyone know WHEN that happens ..ty🙏

0 · Reply

NoFearHere Oct. 3 at 9:31 PM

$QNTM all the quantum stocks are up this one barely perplexing

0 · Reply

Learningtoretire Oct. 3 at 7:33 PM

$QNTM i see the record date 10/27 do you have to hold and maintain those shares until case closes or can you sell after and not lose the dividen?

0 · Reply

James23db Oct. 3 at 3:38 PM

$GNS I’d put a heavy bet on dividends being PR’d here just like $QNTM BEFORE we get a filing from Wes. I don’t even know if it will help bring volume but maybe 🤷🏻‍♂️

2 · Reply

makedatbread88 Oct. 3 at 2:44 PM

$QNTM adding here looks good $25+ target very thinly traded float looks pretty much locked

1 · Reply

Learningtoretire Oct. 3 at 2:26 PM

$QNTM yeah same strategy as GNS sounds great until you realize can take years. to many plays are going to pop off before this happens yeah this may move a little but ill be back as we get close

0 · Reply

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

Oct 2, 2025, 7:57 AM EDT - 5 days ago

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Oct 1, 2025, 7:50 AM EDT - 6 days ago

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Sep 29, 2025, 7:40 AM EDT - 8 days ago

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Sep 26, 2025, 8:00 PM EDT - 10 days ago

Quantum BioPharma Announces Corporate Updates

Sep 24, 2025, 8:30 AM EDT - 13 days ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Sep 18, 2025, 8:10 AM EDT - 19 days ago

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Sep 12, 2025, 7:50 AM EDT - 25 days ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Sep 10, 2025, 7:00 AM EDT - 27 days ago

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Aug 11, 2025, 6:32 PM EDT - 2 months ago

Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 11, 2025, 7:40 AM EDT - 2 months ago

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Aug 8, 2025, 8:00 AM EDT - 2 months ago

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Aug 7, 2025, 7:00 AM EDT - 2 months ago

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Aug 5, 2025, 7:34 AM EDT - 2 months ago

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Aug 4, 2025, 7:33 AM EDT - 2 months ago

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Jul 31, 2025, 7:24 AM EDT - 2 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Jul 30, 2025, 4:00 PM EDT - 2 months ago

Quantum BioPharma Shares' Rollercoaster Day: What's Going On?

Jul 22, 2025, 7:00 AM EDT - 2 months ago

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

GME

Jun 27, 2025, 4:30 PM EDT - 3 months ago

Quantum BioPharma Announces Private Placement

Jun 26, 2025, 7:30 AM EDT - 3 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 18, 2025, 9:19 AM EDT - 3 months ago

Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Jun 17, 2025, 8:00 AM EDT - 4 months ago

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Jun 13, 2025, 7:00 AM EDT - 4 months ago

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Jun 3, 2025, 7:50 AM EDT - 4 months ago

Quantum BioPharma Clarifies It Has Not Changed Its Name

Jun 2, 2025, 1:47 PM EDT - 4 months ago

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

May 30, 2025, 7:00 AM EDT - 4 months ago

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 29, 2025, 7:30 AM EDT - 4 months ago

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

May 28, 2025, 8:00 AM EDT - 4 months ago

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome

May 20, 2025, 7:30 AM EDT - 5 months ago

Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis

May 19, 2025, 7:30 AM EDT - 5 months ago

Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to USD $4,500,000

May 16, 2025, 7:30 AM EDT - 5 months ago

Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference

May 12, 2025, 8:00 AM EDT - 5 months ago

Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis

May 6, 2025, 8:25 PM EDT - 5 months ago

Quantum BioPharma Ltd. (QNTM) Business Update Conference Call Transcript

May 5, 2025, 7:08 AM EDT - 5 months ago

Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

Apr 24, 2025, 7:00 AM EDT - 5 months ago

Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time

Apr 22, 2025, 7:00 AM EDT - 6 months ago

Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor

Apr 18, 2025, 8:00 PM EDT - 6 months ago

Quantum BioPharma Corporate Update

Apr 14, 2025, 7:30 AM EDT - 6 months ago

Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario

Apr 3, 2025, 7:00 AM EDT - 6 months ago

Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico

Apr 1, 2025, 2:00 AM EDT - 6 months ago

Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis

Mar 31, 2025, 7:00 AM EDT - 6 months ago

Quantum Biopharma Announces Closing of Final $2.42 Million Tranche of $5 Million Total Financing on Improved Terms

Mar 30, 2025, 7:00 PM EDT - 6 months ago

Quantum BioPharma Provides Corporate Update

Mar 28, 2025, 4:38 PM EDT - 6 months ago

Overlooked Stock: QNTM

Mar 28, 2025, 9:15 AM EDT - 6 months ago

Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

Mar 20, 2025, 7:30 AM EDT - 7 months ago

Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies

Mar 17, 2025, 3:33 PM EDT - 7 months ago

Quantum BioPharma Unaware of Any Material Change

Feb 11, 2025, 7:30 AM EST - 8 months ago

Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Feb 10, 2025, 7:30 AM EST - 8 months ago

Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs

Feb 6, 2025, 7:30 AM EST - 8 months ago

Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study

Feb 4, 2025, 7:03 AM EST - 8 months ago

Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial

HeyHoser Oct. 7 at 1:55 PM

$QNTM no biggie.

0 · Reply

NeckDart Oct. 6 at 10:54 PM

$CCCX $QBTS $RGTI $QNTM 🤟

0 · Reply

gloryb Oct. 6 at 9:19 PM

$QNTM fkn joke

0 · Reply

NoFearHere Oct. 6 at 7:57 PM

$QNTM the dividend is only based upon receiving the money from the lawsuit any appeal process and etc etc will eliminate the date of the Divi and the Divi itself if they lose

0 · Reply

NoFearHere Oct. 6 at 3:11 PM

$QNTM well a DIVY is expected once court decisions reached...anyone know WHEN that happens ..ty🙏

0 · Reply

NoFearHere Oct. 3 at 9:31 PM

$QNTM all the quantum stocks are up this one barely perplexing

0 · Reply

Learningtoretire Oct. 3 at 7:33 PM

$QNTM i see the record date 10/27 do you have to hold and maintain those shares until case closes or can you sell after and not lose the dividen?

0 · Reply

James23db Oct. 3 at 3:38 PM

$GNS I’d put a heavy bet on dividends being PR’d here just like $QNTM BEFORE we get a filing from Wes. I don’t even know if it will help bring volume but maybe 🤷🏻‍♂️

2 · Reply

makedatbread88 Oct. 3 at 2:44 PM

$QNTM adding here looks good $25+ target very thinly traded float looks pretty much locked

1 · Reply

Learningtoretire Oct. 3 at 2:26 PM

$QNTM yeah same strategy as GNS sounds great until you realize can take years. to many plays are going to pop off before this happens yeah this may move a little but ill be back as we get close

0 · Reply

Cristonlois Oct. 3 at 1:14 PM

$GNS filing next week !!!??? $QNTM

0 · Reply

deedee12 Oct. 3 at 12:33 PM

https://x.com/QuantumBP/status/1974069941482516951 $QNTM $RY $CM $700,000,000 Dividend News

1 · Reply

PETER__BANKS Oct. 3 at 11:03 AM

$QNTM - Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

0 · Reply

StockFlips Oct. 3 at 10:14 AM

☕️ let’s get it! What are we feeling? $AREB $UPXI $PAPL $QNTM $ASTC

0 · Reply

Thestocktraderhubzee Oct. 3 at 10:09 AM

WATCHLIST OCT 03 2025. $NFLX Netflix shares are trading lower amid continued weakness possibly after Elon Musk recently called on followers to cancel their Netflix streaming subscriptions. $CANG Cango Inc. Announces September 2025 Bitcoin Production Of 616.6 BTC With 20.55 BTC Per Day Average Output $RIOT Northland Capital Markets Maintains Outperform on Riot Platforms, Raises Price Target to $24.5 $QNTM Quantum Biopharma shares are trading higher after the company announced it received two key final reports related to its potential breakthrough drug for Multiple Sclerosis. $JAZZ FDA Approves Lurbinectedin In Combination With Atezolizumab Or Atezolizumab And Hyaluronidase-tqjs For Extensive-Stage Small Cell Lung Cancer

0 · Reply

HouseOfTheDragons Oct. 3 at 2:58 AM

Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $CAPT $QNTM $CPIX $LXEH nx

0 · Reply

HouseOfTheDragons Oct. 3 at 2:56 AM

0 · Reply

MarketParadise Oct. 3 at 1:52 AM

Everyone should have ticker GIPR on their watch!🚨🚨 GIPR might be the most obvious setup on the market right now. It has $100M+ in property. It gets rent from companies you shop at. And it’s still under the radar. hot list $AEMD $IMRX $QNTM $FOFO

0 · Reply

Rambler1111 Oct. 2 at 8:13 PM

$QNTM Very Exciting as the I’s and T’s are getting crossed before the phase 2 trial gets started upon approval from the FDA. Les grow!!!

0 · Reply

NoFearHere Oct. 2 at 7:25 PM

$QNTM Quantum Biopharma's MS drug, Lucid-MS, has the potential to be better than existing treatments because it is designed to repair nerve damage, which current therapies cannot do. However, it is not yet available, and its effectiveness in humans has not been confirmed. It is still in the early stages of the clinical trial process. How Lucid-MS is different from existing treatments A different target: Lucid-MS (also known as Lucid-21-302) is a "neuroprotective compound" that works by blocking certain enzymes called peptidyl arginine deiminases (PADs). These enzymes are overactive in MS and contribute to nerve damage. Repairs nerve damage: Current MS drugs primarily focus on suppressing the immune system to reduce inflammation, which helps slow disease progression but cannot reverse existing nerve damage. Preclinical studies in animal models suggest that

1 · Reply

Wearewhowethought Oct. 2 at 6:58 PM

$GNS $QNTM $BTC.X roger is up 3 million$ on hid bitcoin treasury buys yes shares price is lower. roger is up on $QNTM share purchase green all over yet the market maker wants retail to believ that quanitfies to .01 gains on gns stock lol sure

0 · Reply

Unalloyed Oct. 2 at 6:54 PM

$QNTM https://www.globenewswire.com/news-release/2025/10/02/3160289/0/en/Quantum-BioPharma-Receives-Final-Reports-for-Two-Key-Studies-of-its-Potential-Breakthrough-Drug-for-Multiple-Sclerosis-Moving-Closer-to-Phase-2-Clinical-Trial.html

0 · Reply

Market Cap	70.40M
Revenue (ttm)	0.00
Net Income (ttm)	-14.20M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	123,000
Avg Vol	154,808
Day's Range	N/A - N/A
Shares Out	3.82M
Stochastic %K	63%
Beta	0.70
Analysts	Sell
Price Target	$35.50